[Federal Register Volume 65, Number 95 (Tuesday, May 16, 2000)]
[Notices]
[Pages 31192-31193]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-12251]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Agency Information Collection Activities: Proposed Collection; 
Comment Request

ACTION: Notice of information collection under review; extension of a 
currently approved collection: Collection of Laboratory Analysis Data 
on Drug Samples Tested by Non-Federal (State and Local Government) 
Crime Laboratories.

-----------------------------------------------------------------------

    This proposed information collection is published to obtain 
comments from the public and affected agencies. Comments are encouraged 
and will be accepted until July 17, 2000. Written comments and 
suggestions are requested from the public and affected agencies 
concerning the proposed collection of information.
    Your comments should address one or more of the following four 
points:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.
    If you have comments, suggestions, or need a copy of the proposed 
information collection instrument with instructions, if applicable, or 
additional information, please contact Frank L. Sapienza, Chief, Drug & 
Chemical Evaluation Section, Office of Diversion Control, Drug 
Enforcement Administration, Washington, DC 20537, Telephone (202) 307-
7183.

    Overview of this information collection:
    (1) Type of information collection: Extension of a currently 
approved collection.
    (2) The title of the form/collection: Collection of Laboratory 
Analysis Data on Drug Samples Tested by Non-Federal (State and Local 
Government) Crime Laboratories.

[[Page 31193]]

    (3) The agency form number, if any, and the applicable component of 
the Department sponsoring the collection:
    Form No.: None.
    Applicable component of the Department sponsoring the collection: 
Office of Diversion Control, Drug Enforcement Administration, U.S. 
Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract: Primary: Regulatory or Compliance.
    Other: Research.
    Abstract: Information is needed from state and local laboratories 
to provide DEA with additional analyzed drug information for the 
National Forensic Laboratory Information System.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond/reply: 100 
respondents; 1200 responses per year  x  .25 hours per response = 300 
hrs.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: 300 annual burden hours; 100 respondents  x  3 
hours per respondent per year.
    If additional information is required contact: Mr. Robert B. 
Briggs, Clearance Officer, United States Department of Justice, 
Information Management and Security Staff, Justice Management Division, 
Suite 1221, National Place Building, 1331 Pennsylvania Ave., NW., 
Washington, DC 20530.

    Dated: May 9, 2000.
Robert B. Briggs,
Department Clearance Officer, United States Department of Justice.
[FR Doc. 00-12251 Filed 5-15-00; 8:45 am]
BILLING CODE 4410-09-M